Healthcare
For more than 30 years, Alcimed has been supporting the leaders of the healthcare sector in their innovation and new market development projects.
Our activities for healthcare players
The explorers of Alcimed’s healthcare team support everyday pharmaceutical companies, biotechs, but also medical device, diagnostic, vaccine and animal health players in a wide variety of challenges linked to the healthcare sector: evolution of care pathways, innovative therapies, AI in healthcare, digitization of clinical trials, market access, and more.
They trust us
Some examples of projects carried out for our clients
Our projects cover diverse subjects such as new therapeutic technologies and approaches, preparing for new medication launches, understanding the management of diseases and care pathways, evaluating market opportunities and licensing, market access, regulatory evolution, and many more!
Optimization of the care pathway of rare disease patients in 8 European countries
Development of the homecare strategy of a medical device player
Analysis of patients’ emotions
Develop services that improve their quality of life at every stage of the patient pathway
Prospective study of the mRNA-based therapies market in oncology
State of the art of digital healthcare objects on the European, American and Asian markets
Smart data
Development of the patient data acquisition strategy of a pharmaceutical company to develop a personalized medicine solution
Exploring innovative solutions to improve patient adherence with an e-health solution
Gene therapy
Definition of the market access strategy for a new CAR-T cell therapy in the US, Canada, and Europe
Learn more about our missions and expertise
Our missions
Our expertise
Our missions
Strategic marketing
Clients & Patients
R&D
Commercial strategy
Innovation
New partners
Our expertise
Healthcare
Environment & Climate
Beauty & Nutrition
Energy & mobility
Sovereignty
What they say
"The benefit that really Alcimed brought to the table was to have an expert intermediary to take us through the process to really challenge our thinking."
Mark TWYMAN
Senior VP and Chief Commercial Officer
"Alcimed bring in some cross-industry views, which I just do not have the capacity to see myself."
Philip HO
Global Vaccines Public Affairs
"The Alcimed team has allowed us to structure the project appropriately, to plan it in the best possible way, and to make sure that every single step of the project was successful."
Federico Bianco
Head of the Special Care Unit
"Together between Alcimed and Nestlé Health Science, we made informed decision on where the best opportunities were and why and how to select the most valuable assets in our investigation."
Bernard Cuenoud
Global Head of Research and Clinical Development
"Alcimed support has enabled Boehringer Ingelheim to move forward efficiently on several projects in a structured way."
"The Alcimed team’s support has enabled Boehringer Ingelheim to move forward efficiently on several projects in a structured way over the past two years. The Alcimed team brought a good level of strategic thinking, an open-mindedness and a willingness to entertain new ideas. These assets enabled Alcimed to successfully challenge internal teams and co-build solutions with them. In the same way, the creation of the VPH Hub in Lyon, accompanied by many players in the Lyon Healthcare ecosystem, has progressed in a more organized and efficient way thanks to a team that is both structuring, structured, and ... friendly."
Erick LELOUCHE
President Boehringer Ingelheim France
"Alcimed's support allowed us to have a perfect alignment between the definition of our strategy and its execution."
"I had the chance to work with the Alcimed team in preparing the launch of our first biosimilar in France. Alcimed's support was particularly valuable as it allowed us to have a perfect alignment between the definition of our strategy and its execution, which ultimately contributed to the success of this launch (our product became market leader 12 months after its launch). Alcimed's approach based on a rigorous methodology and the constant search for innovative solutions also allowed us to reinforce the expertise of our internal teams and to create a positive work dynamic. I hope that I will have other opportunities in the future to work with Alcimed's Healthcare team."
Benoit SLAVICEK
Global VP ExCom member
"I really appreciated the execution of the project."
"I recently worked with Alcimed on a project to investigate HCP perception of different future products. I really appreciated the execution of the project on an eye-to-eye level between the teams and the broad language skills and multiculturality in the Alcimed team!"
Dr. Sonja RAUCHSCHWALBE
Vice President Marketing Injectable Drugs
You have a project?
Join our adventure
Embark on our adventure and join a team of 220 explorers from over 20 different nationalities with degrees from the best international universities, passionate about scientific breakthroughs, technological innovations, international development, and challenges in healthcare and climate.
Want to climb aboard?
Pour aller plus loin
Healthcare
AI in medical imaging, a revolution in medical diagnosis and patient care
Artificial intelligence has made its mark in many specialties, such as medical imaging. But how is AI in medical imaging used, and what are the challenges ahead?
Healthcare
5 reasons to focus on patient engagement in R&D: the example of rare diseases
Reason 1: the patients are experts in their disease More than in most fields, rare disease patients occupy a position as “patient expert”, having a unique knowledge of their disease.Directly ...
Healthcare
3 tips for building the future care pathway
Emergency room crisis, doctor shortage, ecology... The future care pathways must respond to a variety of challenges. Here are 3 tips to help you build them.